CBDG — THC Farmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.22m
- $0.13m
- $0.01m
Annual balance sheet for THC Farmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2013 September 30th | R2014 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-Q/A | ARS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.001 | 0.001 | 0.003 | 0.002 | 0.019 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.002 | 0.002 | 0.631 | 0.636 | 0.635 |
| Total Other Current Assets | |||||
| Total Current Assets | 0.002 | 0.002 | 0.658 | 0.663 | 0.679 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.013 | 0.012 | 0.007 | 0.023 | 0.006 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 0.049 | 0.048 | 2.33 | 2.78 | 2.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.003 | 0.084 | 0.551 | 0.142 | 0.588 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.066 | 0.096 | -0.02 | -0.439 | 0.007 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.017 | -0.048 | 2.35 | 3.22 | 2.79 |
| Total Liabilities & Shareholders' Equity | 0.049 | 0.048 | 2.33 | 2.78 | 2.8 |
| Total Common Shares Outstanding |